Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

New compounds show promise as nonsteroidal treatments for hair loss.

Finasteride helps with prostate symptoms but may cause sexual side effects.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The two finasteride tablet brands are bioequivalent.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.